Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus

NCT03052400 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped End of Funding

Conditions

Type 2 Diabetes Mellitus
Insulin Resistance

Interventions

DRUG: Mifepristone 600 mg daily
DRUG: Placebo

Sponsor

Charles Drew University of Medicine and Science